These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 17450340)
21. Routine use of HSV-1 and HSV-2 antibody testing. Nahmias AJ Herpes; 2002 Dec; 9(3):83. PubMed ID: 12470607 [No Abstract] [Full Text] [Related]
22. Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. Manickan E; Kanangat S; Rouse RJ; Yu Z; Rouse BT J Leukoc Biol; 1997 Feb; 61(2):125-32. PubMed ID: 9021916 [TBL] [Abstract][Full Text] [Related]
23. Type I interferons and herpes simplex virus infection: a naked DNA approach as a therapeutic option? Noisakran S; Carr DJ Immunol Res; 2001; 24(1):1-11. PubMed ID: 11485206 [TBL] [Abstract][Full Text] [Related]
24. Potential role of famciclovir for prevention of herpetic whitlow in the health care setting. Manian FA Clin Infect Dis; 2000 Oct; 31(4):E18-9. PubMed ID: 11049807 [TBL] [Abstract][Full Text] [Related]
25. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice. Ghaemi A; Soleimanjahi H; Bamdad T; Soudi S; Arefeian E; Hashemi SM; Ebtekar M Comp Immunol Microbiol Infect Dis; 2007 Jul; 30(4):197-210. PubMed ID: 17335902 [TBL] [Abstract][Full Text] [Related]
26. Herpes simplex: insights on pathogenesis and possible vaccines. Koelle DM; Corey L Annu Rev Med; 2008; 59():381-95. PubMed ID: 18186706 [TBL] [Abstract][Full Text] [Related]
27. Prevalence of herpes simplex virus 1 and 2 antibodies in patients with autism spectrum disorders. Gentile I; Zappulo E; Bonavolta R; Maresca R; Riccio MP; Buonomo AR; Portella G; Vallefuoco L; Settimi A; Pascotto A; Borgia G; Bravaccio C In Vivo; 2014; 28(4):667-71. PubMed ID: 24982239 [TBL] [Abstract][Full Text] [Related]
28. Herpes simplex virus type 1 envelope subunit vaccine not only protects against lethal virus challenge, but also may restrict latency and virus reactivation. Rajcáni J; Sabó A; Mucha V; Kostál M; Compel P Acta Virol; 1995 Feb; 39(1):37-49. PubMed ID: 7572468 [TBL] [Abstract][Full Text] [Related]
29. [Herpes simplex virus type 1 and 2]. Yoshida M Nihon Rinsho; 2010 Jun; 68 Suppl 6():306-9. PubMed ID: 20942065 [No Abstract] [Full Text] [Related]
32. Coexpression of interleukin-2 enhances the immunization effect of a DNA vaccine expressing herpes simplex 1 glycoprotein D. Li WR; Niu B; Wang JW; Feng ZJ; Wang DX Acta Virol; 2006; 50(4):251-6. PubMed ID: 17177610 [TBL] [Abstract][Full Text] [Related]